MMI raises $125 million Series D for Symani commercial expansion - 2026-10-08 - Funding - Approximately 50 Symani systems are installed, with 3,500 complex microsurgical procedures performed worldwide. Proceeds support expansion in the United States and other markets, clinical evidence including REMIND, and… - source: globenewswire.com
MMI receives FDA approval to expand REMIND microsurgery study - 2026-07-30 - Regulatory - The supplement followed FDA review of 30-day safety data from the first patient cohort. REMIND evaluates Symani-enabled microsurgical techniques intended to re-establish deep-cervical lymphatic drainage in patients with Alzheimer's… - source: globenewswire.com